Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 01/10/2024 - 14:53
  • Read more about Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study

Sodium intake and the risk of various types of cardiovascular diseases: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 01/10/2024 - 14:51
  • Read more about Sodium intake and the risk of various types of cardiovascular diseases: a Mendelian randomization study

The causal effects between gut microbiota and hemorrhagic stroke: a bidirectional two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 01/10/2024 - 14:48
  • Read more about The causal effects between gut microbiota and hemorrhagic stroke: a bidirectional two-sample Mendelian randomization study

Hypertension mediated the effects of pericardial adipose tissue on cardiovascular diseases

Submitted by Viola Mäkelä on Tue, 01/09/2024 - 10:23
  • Read more about Hypertension mediated the effects of pericardial adipose tissue on cardiovascular diseases

Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study

Submitted by Viola Mäkelä on Mon, 01/08/2024 - 13:06
  • Read more about Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study

Mendelian randomization study of lipid metabolism characteristics and migraine risk

Submitted by Viola Mäkelä on Mon, 01/08/2024 - 13:04
  • Read more about Mendelian randomization study of lipid metabolism characteristics and migraine risk

Evaluation of the causal effects of blood metabolites on irritable bowel syndrome: Mendelian randomization

Submitted by Viola Mäkelä on Mon, 01/08/2024 - 12:56
  • Read more about Evaluation of the causal effects of blood metabolites on irritable bowel syndrome: Mendelian randomization

Genome-wide association and Mendelian randomization analysis provide insights into the shared genetic architecture between high-dimensional electrocardiographic features and ischemic heart disease

Submitted by Viola Mäkelä on Mon, 01/08/2024 - 12:52
  • Read more about Genome-wide association and Mendelian randomization analysis provide insights into the shared genetic architecture between high-dimensional electrocardiographic features and ischemic heart disease

Causal relationship between gut microbiota and tuberculosis: a bidirectional two-sample Mendelian randomization analysis

Submitted by Viola Mäkelä on Fri, 01/05/2024 - 15:12
  • Read more about Causal relationship between gut microbiota and tuberculosis: a bidirectional two-sample Mendelian randomization analysis

Exome sequencing identifies genes associated with sleep-related traits

Submitted by Viola Mäkelä on Fri, 01/05/2024 - 15:06
  • Read more about Exome sequencing identifies genes associated with sleep-related traits

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 314
  • Page 315
  • Page 316
  • Page 317
  • Current page 318
  • Page 319
  • Page 320
  • Page 321
  • Page 322
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement